E-LIB Suche - Ergebnisse für: Mimura, Tomoko

1

A Case of Chronic Hepatitis B in which HBs Antigen Seroclea..:

Mimura, Shima ; Ono, Masafumi ; Fujita, Koji...
Internal Medicine. , 2024

Link: https://doi.org/10.2169/..

2

Management of hepatocellular carcinoma, an important cause ..:

Tadokoro, Tomoko ; Nomura, Takako ; Fujita, Koji...
BMC Gastroenterology. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Effectiveness of edoxaban in portal vein thrombosis associa..:

Tadokoro, Tomoko ; Tani, Joji ; Manabe, Takushi...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Relationship between Accurate Diagnosis of Sarcopenia and P..:

Oura, Kyoko ; Morishita, Asahiro ; Manabe, Takushi...
Cancers. 15 (2023) 12 - p. 3243 , 2023

Link: https://doi.org/10.3390/..

5

Pegylated interferon therapy-related microRNA-6126 downregu..:

Fujita, Koji ; Nishitsuji, Hironori ; Iwama, Hisakazu...
Gene. 853 (2023) - p. 147068 , 2023

Link: https://doi.org/10.1016/..

6

Risk factors for CAR‐T cell manufacturing failure among DLB..:

Jo, Tomoyasu ; Yoshihara, Satoshi ; Okuyama, Yoshiki...
British Journal of Haematology. 202 (2023) 2 - p. 256-266 , 2023

Link: https://doi.org/10.1111/..

7

FNAIT pathogenesis determined by serial analysis of three s..:

Kiyokawa, Tomoko ; Mimura, Kazuya ; Nagamine, Keisuke...
International Journal of Hematology. 118 (2023) 1 - p. 146-150 , 2023

Link: https://doi.org/10.1007/..

8

Efficacy and outcome of molecular targeted therapies in eld..:

Oura, Kyoko ; Morishita, Asahiro ; Takuma, Kei...
Cancer Medicine. 12 (2023) 24 - p. 22023-22037 , 2023

Link: https://doi.org/10.1002/..

9

Prognostic Value of Skeletal Muscle Loss in Patients with H..:

Oura, Kyoko ; Morishita, Asahiro ; Tani, Joji...
Cancers. 15 (2023) 6 - p. 1834 , 2023

Link: https://doi.org/10.3390/..

10

Prognostic Value of Skeletal Muscle Loss in Patients with H..:

Kyoko Oura ; Asahiro Morishita ; Joji Tani...
Cancer Therapy. , 2023

Link: https://doi.org/10.3390/..

11

Efficacy and outcome of molecular targeted therapies in eld..:

Oura, Kyoko ; Morishita, Asahiro ; Takuma, Kei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757153/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Risk factors for CAR-T cell manufacturing failure among DLB..:

Jo, Tomoyasu ; Yoshihara, Satoshi ; Okuyama, Yoshiki...
10.1111/bjh.18831. , 2023

Link: http://hdl.handle.net/24..

13

Prognostic Value of Skeletal Muscle Loss in Patients with H..:

Kyoko Oura ; Asahiro Morishita ; Joji Tani...
https://www.mdpi.com/2072-6694/15/6/1834. , 2023

Link: https://doi.org/10.3390/..

14

Prognostic Value of Skeletal Muscle Loss in Patients with H..:

Oura, Kyoko ; Morishita, Asahiro ; Tani, Joji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047018/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Efficacy and outcome of molecular targeted therapies in eld..:

Kyoko Oura ; Asahiro Morishita ; Kei Takuma...
https://doi.org/10.1002/cam4.6783. , 2023

Link: https://doi.org/10.1002/..